FDA Investigator

Lucilla Facchin

Latest inspection on record: Washington, United States, June 2026 · records back to 2023

Human DrugsMedical Devices & Rad HealthBiologics

FDA inspection record · Last updated August 15, 2026

Overview

  • 34 inspections across 34 sites are on record.
  • 11 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-10.

At a glance

Inspections

34

Sites

34

Observations

11

Career since

Feb 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Joshua E. Reuss, MD10 Jun 2026Human Drugs
Nathan A. Boggs, M.D.15 May 2026Human Drugs
Christopher R. DeFilippi, MD24 Apr 2026Medical Devices & Rad Health
Alejandra M.L. Romeo20 Mar 2026Human DrugsView 483 →
Dr. Juan Manuel Puig13 Mar 2026Human Drugs

Sites inspected

Joshua E. Reuss, MDWashington, United States1 insp.
Nathan A. Boggs, M.D.Bethesda, United States1 insp.
Christopher R. DeFilippi, MDFalls Church, United States1 insp.
Alejandra M.L. RomeoCiudad Autonoma Buenos Aires, Argentina1 insp.
Dr. Juan Manuel PuigSan Juan, Argentina1 insp.

Co-investigators

Investigators who share inspections with this person.

David L Chon8 shared
Anthony J Orencia1 shared
Kerun Hardeo1 shared
Koffi A Amegadje1 shared

Full investigator report

Get the verbatim findings behind Lucilla Facchin's 11 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site